Clinical Trial Update: Topical CBD for Musculoskeletal Pain [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial of topical CBD for musculoskeletal pain was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Musculoskeletal Pain

Drugs mentioned

• CBD topical (cannabidiol)

Snippet

Sponsor: University of Virginia | Conditions: Musculoskeletal Pain | Phase 2, Phase 3 | Status: WITHDRAWN